Market Analysis and Insights: Global Biologics Safety Testing Market
The global Biologics Safety Testing market is projected to grow from US$ 2653.5 million in 2023 to US$ 3976.4 million by 2029, at a Compound Annual Growth Rate (CAGR) of 7.0% during the forecast period.
Biologics are advanced drugs used in treatment of cancer, rheumatoid arthritis, and other diseases. These biologics constitutes large molecules such as monoclonal antibodies, recombinant proteins and their safety ensures patient safety as these are used in the treatment of different diseases.
Report Includes
This report presents an overview of global market for Biologics Safety Testing market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Biologics Safety Testing, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Biologics Safety Testing, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Biologics Safety Testing revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Biologics Safety Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Biologics Safety Testing revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Lonza Group, Charles River, Merck, SGS, WuXi AppTec, Thermo Fisher Scientific, Sartorius, Cytovance Biologics and Pace Analytical Services, etc.
By Company
Lonza Group
Charles River
Merck
SGS
WuXi AppTec
Thermo Fisher Scientific
Sartorius
Cytovance Biologics
Pace Analytical Services
Toxikon
Segment by Type
Endotoxin Tests
Sterility Tests
Cell Line Authentication and Characterization Tests
Bioburden Tests
Cell Line Authentication
Residual Host Contaminant Detection Tests
Adventitious Agent Detection Tests
Others
Segment by Application
Pharmaceutical
Medical Research
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East, Africa, and Latin America
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Biologics Safety Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biologics Safety Testing companies鈥� competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biologics Safety Testing revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biologics Safety Testing Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Endotoxin Tests
1.2.3 Sterility Tests
1.2.4 Cell Line Authentication and Characterization Tests
1.2.5 Bioburden Tests
1.2.6 Cell Line Authentication
1.2.7 Residual Host Contaminant Detection Tests
1.2.8 Adventitious Agent Detection Tests
1.2.9 Others
1.3 Market by Application
1.3.1 Global Biologics Safety Testing Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Pharmaceutical
1.3.3 Medical Research
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biologics Safety Testing Market Perspective (2018-2029)
2.2 Global Biologics Safety Testing Growth Trends by Region
2.2.1 Biologics Safety Testing Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Biologics Safety Testing Historic Market Size by Region (2018-2023)
2.2.3 Biologics Safety Testing Forecasted Market Size by Region (2024-2029)
2.3 Biologics Safety Testing Market Dynamics
2.3.1 Biologics Safety Testing Industry Trends
2.3.2 Biologics Safety Testing Market Drivers
2.3.3 Biologics Safety Testing Market Challenges
2.3.4 Biologics Safety Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Biologics Safety Testing by Players
3.1.1 Global Biologics Safety Testing Revenue by Players (2018-2023)
3.1.2 Global Biologics Safety Testing Revenue Market Share by Players (2018-2023)
3.2 Global Biologics Safety Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Biologics Safety Testing, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Biologics Safety Testing Market Concentration Ratio
3.4.1 Global Biologics Safety Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biologics Safety Testing Revenue in 2022
3.5 Global Key Players of Biologics Safety Testing Head office and Area Served
3.6 Global Key Players of Biologics Safety Testing, Product and Application
3.7 Global Key Players of Biologics Safety Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Biologics Safety Testing Breakdown Data by Type
4.1 Global Biologics Safety Testing Historic Market Size by Type (2018-2023)
4.2 Global Biologics Safety Testing Forecasted Market Size by Type (2024-2029)
5 Biologics Safety Testing Breakdown Data by Application
5.1 Global Biologics Safety Testing Historic Market Size by Application (2018-2023)
5.2 Global Biologics Safety Testing Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Biologics Safety Testing Market Size (2018-2029)
6.2 North America Biologics Safety Testing Market Size by Type
6.2.1 North America Biologics Safety Testing Market Size by Type (2018-2023)
6.2.2 North America Biologics Safety Testing Market Size by Type (2024-2029)
6.2.3 North America Biologics Safety Testing Market Share by Type (2018-2029)
6.3 North America Biologics Safety Testing Market Size by Application
6.3.1 North America Biologics Safety Testing Market Size by Application (2018-2023)
6.3.2 North America Biologics Safety Testing Market Size by Application (2024-2029)
6.3.3 North America Biologics Safety Testing Market Share by Application (2018-2029)
6.4 North America Biologics Safety Testing Market Size by Country
6.4.1 North America Biologics Safety Testing Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Biologics Safety Testing Market Size by Country (2018-2023)
6.4.3 North America Biologics Safety Testing Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Biologics Safety Testing Market Size (2018-2029)
7.2 Europe Biologics Safety Testing Market Size by Type
7.2.1 Europe Biologics Safety Testing Market Size by Type (2018-2023)
7.2.2 Europe Biologics Safety Testing Market Size by Type (2024-2029)
7.2.3 Europe Biologics Safety Testing Market Share by Type (2018-2029)
7.3 Europe Biologics Safety Testing Market Size by Application
7.3.1 Europe Biologics Safety Testing Market Size by Application (2018-2023)
7.3.2 Europe Biologics Safety Testing Market Size by Application (2024-2029)
7.3.3 Europe Biologics Safety Testing Market Share by Application (2018-2029)
7.4 Europe Biologics Safety Testing Market Size by Country
7.4.1 Europe Biologics Safety Testing Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Biologics Safety Testing Market Size by Country (2018-2023)
7.4.3 Europe Biologics Safety Testing Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Biologics Safety Testing Market Size (2018-2029)
8.2 China Biologics Safety Testing Market Size by Type
8.2.1 China Biologics Safety Testing Market Size by Type (2018-2023)
8.2.2 China Biologics Safety Testing Market Size by Type (2024-2029)
8.2.3 China Biologics Safety Testing Market Share by Type (2018-2029)
8.3 China Biologics Safety Testing Market Size by Application
8.3.1 China Biologics Safety Testing Market Size by Application (2018-2023)
8.3.2 China Biologics Safety Testing Market Size by Application (2024-2029)
8.3.3 China Biologics Safety Testing Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Biologics Safety Testing Market Size (2018-2029)
9.2 Asia Biologics Safety Testing Market Size by Type
9.2.1 Asia Biologics Safety Testing Market Size by Type (2018-2023)
9.2.2 Asia Biologics Safety Testing Market Size by Type (2024-2029)
9.2.3 Asia Biologics Safety Testing Market Share by Type (2018-2029)
9.3 Asia Biologics Safety Testing Market Size by Application
9.3.1 Asia Biologics Safety Testing Market Size by Application (2018-2023)
9.3.2 Asia Biologics Safety Testing Market Size by Application (2024-2029)
9.3.3 Asia Biologics Safety Testing Market Share by Application (2018-2029)
9.4 Asia Biologics Safety Testing Market Size by Region
9.4.1 Asia Biologics Safety Testing Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Biologics Safety Testing Market Size by Region (2018-2023)
9.4.3 Asia Biologics Safety Testing Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Biologics Safety Testing Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Biologics Safety Testing Market Size by Type
10.2.1 Middle East, Africa, and Latin America Biologics Safety Testing Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Biologics Safety Testing Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Biologics Safety Testing Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Biologics Safety Testing Market Size by Application
10.3.1 Middle East, Africa, and Latin America Biologics Safety Testing Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Biologics Safety Testing Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Biologics Safety Testing Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Biologics Safety Testing Market Size by Country
10.4.1 Middle East, Africa, and Latin America Biologics Safety Testing Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Biologics Safety Testing Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Biologics Safety Testing Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Lonza Group
11.1.1 Lonza Group Company Details
11.1.2 Lonza Group Business Overview
11.1.3 Lonza Group Biologics Safety Testing Introduction
11.1.4 Lonza Group Revenue in Biologics Safety Testing Business (2018-2023)
11.1.5 Lonza Group Recent Developments
11.2 Charles River
11.2.1 Charles River Company Details
11.2.2 Charles River Business Overview
11.2.3 Charles River Biologics Safety Testing Introduction
11.2.4 Charles River Revenue in Biologics Safety Testing Business (2018-2023)
11.2.5 Charles River Recent Developments
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Merck Business Overview
11.3.3 Merck Biologics Safety Testing Introduction
11.3.4 Merck Revenue in Biologics Safety Testing Business (2018-2023)
11.3.5 Merck Recent Developments
11.4 SGS
11.4.1 SGS Company Details
11.4.2 SGS Business Overview
11.4.3 SGS Biologics Safety Testing Introduction
11.4.4 SGS Revenue in Biologics Safety Testing Business (2018-2023)
11.4.5 SGS Recent Developments
11.5 WuXi AppTec
11.5.1 WuXi AppTec Company Details
11.5.2 WuXi AppTec Business Overview
11.5.3 WuXi AppTec Biologics Safety Testing Introduction
11.5.4 WuXi AppTec Revenue in Biologics Safety Testing Business (2018-2023)
11.5.5 WuXi AppTec Recent Developments
11.6 Thermo Fisher Scientific
11.6.1 Thermo Fisher Scientific Company Details
11.6.2 Thermo Fisher Scientific Business Overview
11.6.3 Thermo Fisher Scientific Biologics Safety Testing Introduction
11.6.4 Thermo Fisher Scientific Revenue in Biologics Safety Testing Business (2018-2023)
11.6.5 Thermo Fisher Scientific Recent Developments
11.7 Sartorius
11.7.1 Sartorius Company Details
11.7.2 Sartorius Business Overview
11.7.3 Sartorius Biologics Safety Testing Introduction
11.7.4 Sartorius Revenue in Biologics Safety Testing Business (2018-2023)
11.7.5 Sartorius Recent Developments
11.8 Cytovance Biologics
11.8.1 Cytovance Biologics Company Details
11.8.2 Cytovance Biologics Business Overview
11.8.3 Cytovance Biologics Biologics Safety Testing Introduction
11.8.4 Cytovance Biologics Revenue in Biologics Safety Testing Business (2018-2023)
11.8.5 Cytovance Biologics Recent Developments
11.9 Pace Analytical Services
11.9.1 Pace Analytical Services Company Details
11.9.2 Pace Analytical Services Business Overview
11.9.3 Pace Analytical Services Biologics Safety Testing Introduction
11.9.4 Pace Analytical Services Revenue in Biologics Safety Testing Business (2018-2023)
11.9.5 Pace Analytical Services Recent Developments
11.10 Toxikon
11.10.1 Toxikon Company Details
11.10.2 Toxikon Business Overview
11.10.3 Toxikon Biologics Safety Testing Introduction
11.10.4 Toxikon Revenue in Biologics Safety Testing Business (2018-2023)
11.10.5 Toxikon Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Lonza Group
Charles River
Merck
SGS
WuXi AppTec
Thermo Fisher Scientific
Sartorius
Cytovance Biologics
Pace Analytical Services
Toxikon
听
听
*If Applicable.
